Trial Profile
Efficacy and safety of silodosin and dutasteride combination therapy in acute urinary retention due to benign prostatic hyperplasia: A single-arm prospective study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Feb 2017
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Silodosin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 17 Aug 2015 New trial record